AH
EW icon

Andreas Halvorsen’s Edwards Lifesciences EW Stock Holding History

Andreas Halvorsen’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,097,578
Closed -$87.9M – 98
2026
Q1 		$87.9M Buy
+1,097,578
New +$90.5M 0.25% 67
2025
Q4 		– Sell
-3,069,151
Closed -$239M – 87
2025
Q3 		$239M Buy
+3,069,151
New +$240M 0.62% 50
2020
Q1 		– Sell
-475,719
Closed -$37M – 71
2019
Q4 		$37M Sell
475,719
-136,725
-22% -$10.7M 0.17% 59
2019
Q3 		$44.9M Buy
+612,444
New +$43M 0.23% 48

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Andreas Halvorsen's EW Position: Q2 2026 in Review

Andreas Halvorsen sold out of Edwards Lifesciences (EW) in Q2 2026, closing a stake of 1,097,578 shares — an estimated $87.9M sold.

Andreas Halvorsen first reported a position in EW in Q3 2019 and held it in 4 quarters. The position peaked at $239M in Q3 2025. 1,325 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Andreas Halvorsen reported no remaining Edwards Lifesciences position as of Q2 2026 after selling out during the quarter.
  • Andreas Halvorsen sold 1,097,578 Edwards Lifesciences shares in Q2 2026, an estimated $87.9M.
  • Andreas Halvorsen first reported a position in Edwards Lifesciences in Q3 2019 and held it in 4 quarters.
  • Andreas Halvorsen's Edwards Lifesciences position peaked at $239M in Q3 2025.
  • 1,325 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Viking Global Investors's 13F filing for Q2 2026, filed 14 Aug 2026.